Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Other Non-Current Assets: 2022-2024

Historic Other Non-Current Assets for Abivax (ABVX) over the last 3 years, with Dec 2024 value amounting to $6.4 million.

  • Abivax's Other Non-Current Assets was N/A to $902,517 in Q1 2025 from the same period last year, while for Mar 2025 it was $902,517, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2024, which is 53.98% down from last year.
  • Latest data reveals that Abivax reported Other Non-Current Assets of $6.4 million as of FY2024, which was down 53.98% from $13.9 million recorded in FY2023.
  • Abivax's 5-year Other Non-Current Assets high stood at $13.9 million for FY2023, and its period low was $6.4 million during FY2024.
  • Moreover, its 3-year median value for Other Non-Current Assets was $12.3 million (2022), whereas its average is $10.9 million.
  • In the last 5 years, Abivax's Other Non-Current Assets rose by 12.82% in 2023 and then tumbled by 53.98% in 2024.
  • Abivax's Other Non-Current Assets (Yearly) stood at $12.3 million in 2022, then increased by 12.82% to $13.9 million in 2023, then slumped by 53.98% to $6.4 million in 2024.